Enbridge Other Non-Current Liabilities increased by 0.7% to $12.38B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.7%, from $13.00B to $12.38B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 7.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.24B | $8.12B | $7.62B | $7.43B | $7.80B | $9.13B | $9.19B | $9.24B | $8.85B | $9.47B | $8.65B | $10.62B | $11.59B | $12.25B | $13.26B | $13.00B | $11.77B | $12.28B | $12.30B | $12.38B |
| QoQ Change | — | -1.5% | -6.1% | -2.4% | +5.0% | +17.1% | +0.6% | +0.5% | -4.2% | +7.0% | -8.6% | +22.7% | +9.1% | +5.8% | +8.2% | -2.0% | -9.4% | +4.3% | +0.2% | +0.7% |
| YoY Change | — | — | — | — | -5.3% | +12.5% | +20.6% | +24.3% | +13.4% | +3.7% | -5.8% | +15.0% | +31.0% | +29.4% | +53.2% | +22.4% | +1.6% | +0.2% | -7.2% | -4.7% |